CRP Test
CRP Test
Implication
Positive: Agglutination is observed if there is presence of detectable levels of CRP in the test
specimen (Qualitative method). Semi quantitative is performed when the qualitative method is
positive. Using isotonic saline, prepare serial dilution of the test specimen positive in the
qualitative method.
Significance
In general, the result is reported in either mg/dL or mg/L. When used for cardiac risk
stratification, hs-CRP levels less than 1 mg/dL are considered low risk. Levels between 1 mg/dL
and 3 mg/dL are considered a moderate risk and a level greater than 3 mg/dL is considered
high risk for the development of cardiovascular disease.
Less than 0.3 mg/dL: Normal (level seen in most healthy adults).
0.3 to 1.0 mg/dL: Normal or minor elevation (can be seen in obesity, pregnancy, depression,
diabetes, common cold, gingivitis, periodontitis, sedentary lifestyle, cigarette smoking, and
genetic polymorphisms).
1.0 to 10.0 mg/dL: Moderate elevation (Systemic inflammation such as RA, SLE or other
autoimmune diseases, malignancies, myocardial infarction, pancreatitis, bronchitis).
More than 10.0 mg/dL: Marked elevation (Acute bacterial infections, viral infections, systemic
vasculitis, major trauma).
More than 50.0 mg/dL: Severe elevation (Acute bacterial infections).
Yes, although it is a non-specific test, is still considered important because it complements other
tests to assess the person’s risk in developing disease. For example, in assessing the risk of
cardiovascular disease, cholesterol is routinely requested. Elevated cholesterol levels are
associated with ‘plaque buildup’ and increased risk of heart attack. Measuring active
inflammation by CRP tests may show how prone a ‘plaque’ is to rupture.
CRP is a direct and quantitative measure of the acute-phase reaction and provides adequate
information about the actual clinical situation. In rheumatoid arthritis (RA), the CRP level reflects
short-term and long-term disease activity. In disorders such as RA, CRP can be used to assess
the effect of anti-inflammatory drugs
and the nature of their action. Levels of CRP rise after tissue injury or surgery. If the CRP level
is persistently elevated or returns to an increased level, it may indicate underlying sepsis.
Because CRP is non-specific, it is an unreliable indicator. CRP values may be normal when
other acute-phase proteins are altered in disorders such as SLE, dermatomyositis, and
ulcerative colitis. For example, SLE shows no CRP response, despite apparently active
inflammation.
4. What are factors that could affect our results? In the clinical laboratory setting, how do
we minimize introducing errors in our testing? Be specific.
False Decrease
Use of non-steroidal anti-inflammatory drugs (NSAIDS)
Statins
Recent injury or illness particularly when using CRP test for cardiac risk stratification
Magnesium supplementation
Mild elevation in CRP can be seen without any systemic or inflammatory disease. Females and
elderly patients usually have higher CRP levels. Obesity, insomnia, depression, smoking, and
diabetes can all contribute to mild elevations in CRP.
Sample Preparation
Sample should be freshly collected. If testing is delayed, store samples at 2-8C for 48
hours. Bacterial contamination may cause protein denaturation and false positive result.
Strongly lipemic or contaminated serum can cause false positive reactions.
The presence of RF in serum sample (usually >20 IU/ml) may lead to false positive results.
A prozone phenomena (antigen excess) may cause false negatives. It is advisable to check
all negative serum by retesting at a 1:10 dilution. Reaction times longer than specified may
produce apparent false reactions due to a drying effect.
References:
Bansal, P. et al. (2020). C Reactive Protein (CRP). Retrieved from
https://www.ncbi.nlm.nih.gov/books/NBK441843/
MacCleod, C.M., & O.T.Avery: J. Exper.Med. 73, 191, 1950.
Marcin, J. (2019). C-Reactive Protein Test. Retrieved from https://www.healthline.com/health/c-
reactive-protein
Nehring SM, Goyal A, Bansal P, et al. C Reactive Protein (CRP) [Updated 2020 Jun 5]. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK441843/
Saxtad, J., L.A. Nilsson & L.A. Hanson: Acta Paediat. Scand. 59, 25, 1970.
Sproston, N. R., & Ashworth, J. J. (2018). Role of C-Reactive Protein at Sites of Inflammation
and Infection. Frontiers in immunology, 9, 754. https://doi.org/10.3389/fimmu.2018.00754
Turgeon, M.L. (2014). Immunology & Serology in Laboratory Medicine. Elsevier Inc.